home / stock / csbr / csbr news


CSBR News and Press, Champions Oncology Inc.

Stock Information

Company Name: Champions Oncology Inc.
Stock Symbol: CSBR
Market: NASDAQ
Website: championsoncology.com

Menu

CSBR CSBR Quote CSBR Short CSBR News CSBR Articles CSBR Message Board
Get CSBR Alerts

News, Short Squeeze, Breakout and More Instantly...

CSBR - Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024

HACKENSACK, NJ / ACCESSWIRE / July 11, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its financial and operational results for the fourth quarter and year-ended April 30, 2024, on...

CSBR - Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development

HACKENSACK, NJ / ACCESSWIRE / June 4, 2024 / Champions Oncology, Inc. (Nasdaq:CSBR), a leader in the development of advanced preclinical oncology solutions, has announced a strategic partnership with Medicines Discovery Catapult (MDC), enhancing their combined capabilities in the expanding f...

CSBR - Champions Oncology, Inc. (CSBR) Q3 2024 Earnings Call Transcript

2024-03-12 19:21:03 ET Champions Oncology, Inc. (CSBR) Q3 2024 Earnings Conference Call March 12, 2024 04:30 PM ET Company Participants Ronnie Morris - CEO David Miller - CFO Presentation Operator Greetings. Welcome to the Champions Oncology Third...

CSBR - Champions Oncology Non-GAAP EPS of -$0.16, revenue of $12M

2024-03-12 17:18:28 ET More on Champions Oncology Seeking Alpha’s Quant Rating on Champions Oncology Historical earnings data for Champions Oncology Read the full article on Seeking Alpha For further details see: Champions Oncology Non-GAAP EPS of ...

CSBR - Champions Oncology Reports Quarterly Revenue of $12.0 Million

HACKENSACK, NJ / ACCESSWIRE / March 12, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, today announced its financial results for its third quarter of fiscal 2024, ended January 31, 2024. Thi...

CSBR - Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation

HACKENSACK, NJ / ACCESSWIRE / March 7, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, announced that the College of American Pathologists (CAP) has awarded accreditation to its US-based labora...

CSBR - Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024

HACKENSACK, NJ / ACCESSWIRE / March 6, 2024 / Champions Oncology, Inc. (CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its financial and operational results for the third quarter ended January 31, 2024, on Tuesday, March...

CSBR - (CSBR) Technical Pivots with Risk Controls

2024-01-25 00:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

CSBR - Objective long/short (CSBR) Report

2024-01-14 10:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

CSBR - How To Trade (CSBR)

2024-01-03 15:35:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Next 10